Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance

SIMPLE SUMMARY: The use of targeted therapy has changed the clinical management of lung cancer patients, increasing both their life quality and expectancy. Conversely, the appearance of resistance occurs in almost all patients receiving this therapy. In this regard, new strategies combining differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancini, Maicol, Thomas, Quentin-Dominique, Bourdel, Sylvia, Papon, Laura, Bousquet, Emilie, Jalta, Prisca, La Monica, Silvia, Travert, Camille, Alfieri, Roberta, Quantin, Xavier, Cañamero, Marta, Maraver, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307933/
https://www.ncbi.nlm.nih.gov/pubmed/34298655
http://dx.doi.org/10.3390/cancers13143441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307933/
https://www.ncbi.nlm.nih.gov/pubmed/34298655
http://dx.doi.org/10.3390/cancers13143441

Ejemplares similares